A follow-up analysis of the survival outcomes in both groups revealed that the survival outcome of patients with MPO-ANCA SLE was potentially worse than that of patients with PR3-ANCA SLE, although the difference did not reach statistical significance.
← all excerpts
Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus.
1
—
—